Over the past decade, robotic neurorehabilitation has become one of the most discussed innovations in neurological recovery. Robotic gait trainers, upper-limb rehabilitation systems, exoskeletons, and AI-assisted rehabilitation devices are increasingly being adopted by hospitals and rehabilitation centres worldwide. However, an important question remains: Are robots the future of neurorehabilitation—or are they simply another tool in the rehabilitation toolbox? As clinicians and researchers, we must move beyond marketing claims and focus on scientific evidence, patient selection, and clinical reasoning. What is Robotic Neurorehabilitation? Robotic neurorehabilitation involves the use of electromechanical devices that assist, guide, resist, or augment movement during therapy. These technologies include: • Robotic gait trainers • Wearable exoskeletons • Upper limb robotic rehabilitation devices • End-effector robotic systems • Sensor-based rehabilitation platforms • AI-assiste...
Neuronal Precursor Proliferation Is Enhanced by Cannabinoids Via CB1/AKT/GSK- 3BETA/BETA-Catenin Signaling
The proliferation
of neuronal precursors is enhanced by cannabinoids through a signaling pathway
involving CB1 receptors, AKT, GSK-3beta, and beta-catenin. Here is a breakdown
of the key points related to this mechanism:
1. Cannabinoids and
Neuronal Precursor Proliferation:
o Cannabinoids,
including endocannabinoids and exogenous cannabinoids, have been shown to
promote the proliferation of neuronal precursor cells in the brain.
o This effect of
cannabinoids on neuronal precursor proliferation is of interest for potential
therapeutic applications in neuroregeneration and brain repair.
2. CB1 Receptors:
o Cannabinoid
receptor type 1 (CB1) is a G protein-coupled receptor that is abundantly
expressed in the brain, including regions involved in neurogenesis.
o Activation of CB1
receptors by cannabinoids initiates intracellular signaling cascades that
regulate various cellular processes, including neuronal precursor
proliferation.
3. AKT Signaling
Pathway:
o AKT, also known
as protein kinase B, is a key signaling molecule involved in cell survival,
proliferation, and growth.
o Activation of CB1
receptors by cannabinoids can stimulate the AKT signaling pathway, leading to
the activation of downstream effectors that promote neuronal precursor
proliferation.
4. GSK-3beta and
Beta-Catenin:
o Glycogen synthase
kinase-3 beta (GSK-3beta) is a serine/threonine kinase that regulates various
cellular functions, including cell proliferation and differentiation.
o In the context of
neuronal precursor proliferation, GSK-3beta is known to phosphorylate
beta-catenin, a transcriptional co-activator involved in cell proliferation and
survival.
o Activation of AKT
by CB1 receptor signaling can inhibit GSK-3beta activity, leading to the
stabilization and accumulation of beta-catenin in the nucleus.
5. CB1/AKT/GSK-3beta/Beta-Catenin
Signaling:
o The
CB1/AKT/GSK-3beta/beta-catenin signaling pathway represents a mechanism through
which cannabinoids enhance the proliferation of neuronal precursor cells.
o Activation of CB1
receptors by cannabinoids triggers a cascade of events that ultimately result
in the activation of AKT, inhibition of GSK-3beta, and nuclear translocation of
beta-catenin, promoting cell proliferation.
6. Therapeutic
Implications:
o Understanding the
molecular mechanisms underlying the effects of cannabinoids on neuronal
precursor proliferation can inform the development of novel therapeutic
strategies for promoting neurogenesis and brain repair in various neurological
conditions.
o Targeting the
CB1/AKT/GSK-3beta/beta-catenin pathway may offer potential therapeutic
opportunities for enhancing neuroregeneration and functional recovery in the
brain.
In summary,
cannabinoids enhance neuronal precursor proliferation through the
CB1/AKT/GSK-3beta/beta-catenin signaling pathway, highlighting the potential of
cannabinoid-based therapies for promoting neurogenesis and brain repair.
Comments
Post a Comment